251
252
253
254
255
van den Berg, Bernard, Gafni, Amiram, Portrait, France
Veröffentlicht in: van den Berg , B , Gafni , A & Portrait , F 2017 , ' Attributing a monetary value to patients' time : A contingent valuation approach ' , Social Science & Medicine , vol. 179 , pp. 182-190 . https://doi.org/10.1016/j.socscimed.2017.02.025;
2017
Veröffentlicht in: van den Berg , B , Gafni , A & Portrait , F 2017 , ' Attributing a monetary value to patients' time : A contingent valuation approach ' , Social Science & Medicine , vol. 179 , pp. 182-190 . https://doi.org/10.1016/j.socscimed.2017.02.025;
2017
256
Ramos, Isaac Corro, Versteegh, Matthijs M., de Boer, Rudolf A., Koenders, Jolanda M. A., Linssen, Gerard C. M., Meeder, Joan G., Rutten-van Molken, Maureen P. M. H.
Veröffentlicht in: Ramos , I C , Versteegh , M M , de Boer , R A , Koenders , J M A , Linssen , G C M , Meeder , J G & Rutten-van Molken , M P M H 2017 , ' Cost Effectiveness of the Angiotensin Receptor Neprilysin Inhibitor Sacubitril/Valsartan for Patients with Chronic Heart Failure and Reduced Ejection Fraction in the Netherlands : A Country Adaptation Analysis Under the Former and Current Dutch Pharmacoeconomic Guidelines ' , Value in Health , vol. 20 , no. 10 , pp. 1260-1269 . https://doi.org/10.1016/j.jval.2017.05.013;
2017
Veröffentlicht in: Ramos , I C , Versteegh , M M , de Boer , R A , Koenders , J M A , Linssen , G C M , Meeder , J G & Rutten-van Molken , M P M H 2017 , ' Cost Effectiveness of the Angiotensin Receptor Neprilysin Inhibitor Sacubitril/Valsartan for Patients with Chronic Heart Failure and Reduced Ejection Fraction in the Netherlands : A Country Adaptation Analysis Under the Former and Current Dutch Pharmacoeconomic Guidelines ' , Value in Health , vol. 20 , no. 10 , pp. 1260-1269 . https://doi.org/10.1016/j.jval.2017.05.013;
2017
257
258
259
260